Global Continence

These accolades reflect the confidence of leading experts in our transformative approach to stopping bedwetting through gentle neuromodulation. Soluu™ is redefining pediatric urology, bringing hope and real solutions to families worldwide.

Soluu™ has achieved an extraordinary milestone, securing top recognition at every NIH/FDA-sponsored Pediatric Device Consortium (PDC) event, culminating in a Bronze Medal at the UCSF-Stanford PDC presentation at Stanford School of Medicine in 2025.

This clean sweep solidifies Soluu’s position as a leader in pediatric device innovation.

2025

2024

Soluu earned the NIH/FDA Midwest Pediatric Device Consortium Prize, supported by a consortium led by Nationwide Children's Hospital, The Ohio State University, Cleveland Clinic Children's and Cincinnati Children's Hospital Medical Center. 

Soluu Makes It to the Academic Stage

Soluu has been featured in invited international presentations across the globe - USA, Portugal, Mexico, the Dominican Republic, and Brazil. The scientific Medical Community is taking notice as the word spreads about our disruptive innovation in the pediatric incontinence space.

2023

Dr. Kirsch represents Global Continence Inc. at the 11th Annual Symposium for Pediatric Device Innovation, MedTech Conference in Anaheim, CA. This is the 4th win for Soluu at an FDA-sponsored pediatric device pitch contest.

2023

American Urological Association (AUA), through a rigorous and highly competitive selection process, has selected Global Continence Inc. as “one of the most exciting startups in the field of urology in 2023”. This “Shark Tank” format was moderated by Fox Business News anchor, Charlie Garparino. At the close of the event, Soluu received a top recognition from the panel.

2022

American Academy of Pediatrics and SWPDC grants $25,000.00 award to Global Continence's product Soluu - bedwetting mitigation device

2021

$50,000 grant award by the Pennsylvania Pediatric Medical Device Consortium, Children’s Hospital of Philadelphia